Angsana specializes in molecular diagnostics and Pathnova specializes in serology and artificial intelligence.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The partnership focuses on radioligand therapy, cell therapy, and early-phase trials. Singapore General Hospital (SGH) and Novartis Singapore have signed a memorandum of understanding (MoU) to advance ...

Investopedia / Paige McLaughlin Ltd. is a standard abbreviation for "limited," a form of corporate structure available in members of the Commonwealth, including the U.K., Ireland, and Canada.

32 per equity share for the year. This dividend for the year ended 31 March 2024 is subject to the approval of Members at the Annual General Meeting on 28 June 2024 and will be paid on or after 1 ...

Bernstein analyst Florent Cespedes maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £22.90. The company’s shares opened today at p1,443. ...

Hongkong & Shanghai Banking Corporation Ltd. ICICI Bank Ltd. Market Crashes For 5-Sessions In Row: Why Sensex Fell 817 Pts And Nifty Dipped 248 Pts On Monday, February 24? Stock Market Live ...

Licious, backed by Temasek Holdings Pte, aims to become profitable by 2026 as it gears up for a potential IPO valuing over $2 billion. The firm is expanding into brick-and-mortar stores, enhancing ...

GlaxoSmithKline share price jumped more than 17% on Tuesday and extended its surge for the third consecutive session. GlaxoSmithKline shares spiked as much as 17.69% to ₹2,744.95 apiece on the ...

Shares of GlaxoSmithKline Pharmaceuticals Ltd. are trading with gains of 20% on Monday, February 17, bucking in trend in a market where most Nifty 50 constituents are trading with losses. GSK Pharma ...

Commenting on the results, Bhushan Akshikar, MD of GlaxoSmithKline Pharmaceuticals, highlighted the company’s strategic initiatives in strengthening its market presence and enhancing access to ...

GlaxoSmithKline Pharmaceuticals shares hit 20 per cent upper circuit in trade on BSE at Rs 2,421.3 per share. The buying on the counter came after the company posted its Q3 results. Around 9:52 AM, ...